AMRX
Amneal Pharmaceuticals
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: AMRX
- PEG Ratio
Amneal Pharmaceuticals currently trades with a PEG ratio of 0.04, based on Jul 2, 2026 data. Dividing the 43.97 PE ratio by the 1075.0% earnings growth rate produces this figure. Relative to the 3.31 average from the past 4 quarters, the PEG ratio has shrunk by 99%.
AMRX PEG ratio history
Historically, Amneal Pharmaceuticals maintains a PEG ratio averaging 1.83 across the last six years. At 0.04, today's PEG ratio sits 98% lower than its historical average. The six years high came in the Jun 2025 quarter at 7.99, reflecting peak valuation relative to growth. The bottom was reached in the Mar 2026 quarter at 0.03, suggesting favorable value relative to growth during that period.
Amneal Pharmaceuticals PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.34 | 54.78 | 160.5% |
| 2024 | N/A | N/A | 20.8% |
| 2023 | N/A | N/A | 44.2% |
| 2022 | N/A | N/A | -1,328.6% |
| 2021 | N/A | 68.43 | -88.7% |
| 2020 | 0.06 | 7.37 | 122.6% |
| 2019 | N/A | N/A | -1,612.5% |
| 2018 | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A |
| 2015 | N/A | N/A | N/A |
| 2014 | N/A | N/A | N/A |
Amneal Pharmaceuticals PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.03 | 31.87 | 1,075% |
| Dec 2025 | 0.34 | 54.78 | 160.5% |
| Sep 2025 | 4.89 | 500.5 | 102.3% |
| Jun 2025 | 7.99 | 809 | 101.3% |
| Mar 2025 | N/A | N/A | 94.6% |
| Dec 2024 | N/A | N/A | 20.8% |
| Sep 2024 | N/A | N/A | -1,533.3% |
| Jun 2024 | N/A | N/A | -3,900% |
| Mar 2024 | N/A | N/A | 17.8% |
| Dec 2023 | N/A | N/A | 44.2% |
| Sep 2023 | 0.66 | 70.33 | 106.9% |
| Jun 2023 | N/A | N/A | 97.7% |
| Mar 2023 | N/A | N/A | -4,600% |
| Dec 2022 | N/A | N/A | -1,328.6% |
| Sep 2022 | N/A | N/A | -970% |
AMRX average PEG ratio chart
Measured against past performance, AMRX's PEG ratio comes in under the 3 and 5-year averages.
PEG comparison
With a PEG of 0.04, AMRX ranks lower than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 0.6, Amneal Pharmaceuticals's PEG is 93% lower.
AMRX EPS growth
AMRX Price vs fair value
Frequently asked questions
What is Amneal Pharmaceuticals's PEG ratio?
According to Jul 2, 2026 figures, AMRX's PEG ratio stands at 0.04.
What is the 3-year average PEG ratio for Amneal Pharmaceuticals (AMRX)?
Across the past 3 years, AMRX's PEG ratio has centered around 2.78.
What is the 5-year average PEG ratio for Amneal Pharmaceuticals (AMRX)?
Across the past 5 years, AMRX's PEG ratio has centered around 2.61.
What is the highest PEG ratio for AMRX?
AMRX's PEG ratio topped out at 7.99 during the Jun 2025 quarter - the highest in six years.
How does the current PEG ratio for AMRX compare to its historical average?
Compared to the 6-year average, AMRX's PEG ratio sits 98% lower.
Why is Amneal Pharmaceuticals's PEG ratio so low?
The 0.04 PEG ratio for AMRX reflects robust earnings growth outpacing the current valuation.
How is AMRX's PEG ratio calculated (Amneal Pharmaceuticals PEG ratio formula)?
PEG equals PE divided by EPS growth rate (YoY TTM). As of Jul 2, 2026, Amneal Pharmaceuticals carries a PE ratio of 43.97. Earnings grew at 1075.0% over the TTM period ending Mar 2026. Applying the formula, this yields a PEG ratio of 0.04. PEG RATIO(0.04) = PE RATIO(43.97) / EPS GROWTH(1075.0%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.